Vigorita; Ottana; Bisignano, Il Farmaco, 1994, vol. 49, # 3, p. 197 - 200
作者:Vigorita、Ottana、Bisignano
DOI:——
日期:——
METHOD OF TREATING A CONDITION ASSOCIATED WITH NEURODEGENERATION USING INHIBITORS OF OAT3
申请人:Neuropore Therapies, Inc.
公开号:EP3810133A1
公开(公告)日:2021-04-28
WO2019246454A5
申请人:——
公开号:WO2019246454A5
公开(公告)日:2022-06-27
Synthesis and SAR of novel, 4-(phenylsulfamoyl)phenylacetamide mGlu4 positive allosteric modulators (PAMs) identified by functional high-throughput screening (HTS)
作者:Darren W. Engers、Patrick R. Gentry、Richard Williams、Julie D. Bolinger、C. David Weaver、Usha N. Menon、P. Jeffrey Conn、Craig W. Lindsley、Colleen M. Niswender、Corey R. Hopkins
DOI:10.1016/j.bmcl.2010.07.007
日期:2010.9
Herein we disclose the synthesis and SAR of a series of 4-(phenylsulfamoyl)phenylacetamide compounds as mGlu4 positive allosteric modulators (PAMs) that were identified via a functional HTS. An iterative parallel approach to these compounds culminated in the discovery of VU0364439 (11) which represents the most potent (19.8 nM) mGlu4 PAM reported to date.